Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Part 2: Hepatitis B (25 mins)

Gain insights into HBV management; topics include determining when to treat, effective monitoring, and treatment options.
Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH
Oluwaseun Falade-Nwulia, MBBS, MPH
Released: December 17, 2019 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters widget.

Related Content

Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.

Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH Oluwaseun Falade-Nwulia, MBBS, MPH
Physicians: maximum of 1.5 AMA PRA Category 1 Credits US Physicians: maximum of 1.5 Medical Knowledge MOC point(s) Released: December 17, 2019 Expired: No longer available for credit

CCO faculty Paul Kwo, MD, answers FAQs in hepatitis B management including treatment candidacy and duration

Paul Y. Kwo, MD Released: December 4, 2019

HBV slides from the Clinical Care Options Symposium at the liver meeting 2019, with Paul Kwo, MD

Paul Y. Kwo, MD
Program Director
Released: November 11, 2019

Paul Kwo, MD: Expert commentary on closing HBV diagnosis and treatment gaps to reduce complications and effective approaches to patient monitoring

Paul Y. Kwo, MD
Program Director
Released: October 16, 2019

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue